We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

164 hedge funds and large institutions have $1.52B invested in Rocket Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

341% more call options, than puts

Call options by funds: $4.54M | Put options by funds: $1.03M

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

13% more capital invested

Capital invested by funds: $1.34B → $1.52B (+$177M)

13% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 54

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1% more funds holding

Funds holding: 163 → 164 (+1)

3.73% less ownership

Funds ownership: 98.63% → 94.9% (-3.7%)

Holders
164
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
2.57%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
18
Increased
61
Reduced
54
Closed
17
Calls
$4.54M
Puts
$1.03M
Net Calls
+$3.51M
Net Calls Change
+$371K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$20.9M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$8.48M
3
PA
Perceptive Advisors
New York
+$6.07M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.09M
5
PHS
PFM Health Sciences
California
+$4.82M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$19.4M
2
State Street
State Street
Massachusetts
-$17M
3
LGM
Logos Global Management
California
-$13.1M
4
BlackRock
BlackRock
New York
-$6.69M
5
WP
Woodline Partners
California
-$5.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPC
101
Sigma Planning Corp
Michigan
$518K -$30.5K -1,508 -5%
GGHC
102
Gilder Gagnon Howe & Co
New York
$465K -$1.21K -60 -0.3%
Tudor Investment Corp
103
Tudor Investment Corp
Connecticut
$454K +$462K +22,873 New
New York State Common Retirement Fund
104
New York State Common Retirement Fund
New York
$452K -$121K -5,980 -21%
VOYA Investment Management
105
VOYA Investment Management
Georgia
$441K +$33.8K +1,674 +8%
Stifel Financial
106
Stifel Financial
Missouri
$428K +$49.2K +2,436 +13%
CA
107
Cornerstone Advisory
Maryland
$358K -$1.56M -77,000 -81%
Envestnet Asset Management
108
Envestnet Asset Management
Illinois
$347K +$67.8K +3,356 +24%
Principal Financial Group
109
Principal Financial Group
Iowa
$344K +$26.9K +1,333 +8%
EAM
110
Erste Asset Management
Austria
$335K – – –
DIA
111
Dana Investment Advisors
Wisconsin
$332K +$18.8K +931 +6%
Squarepoint
112
Squarepoint
New York
$329K +$335K +16,561 New
AWM
113
Avior Wealth Management
Nebraska
$323K -$18.1K -894 -5%
State Board of Administration of Florida Retirement System
114
State Board of Administration of Florida Retirement System
Florida
$317K -$11.3K -560 -3%
ASRS
115
Arizona State Retirement System
Arizona
$310K -$30.5K -1,508 -9%
Teacher Retirement System of Texas
116
Teacher Retirement System of Texas
Texas
$300K -$62.8K -3,109 -17%
PNC Financial Services Group
117
PNC Financial Services Group
Pennsylvania
$295K +$9.7K +480 +3%
VF
118
Virtu Financial
New York
$287K +$292K +14,435 New
YIH
119
Y-Intercept (HK)
Hong Kong
$280K +$285K +14,089 New
EFM
120
E Fund Management
China
$249K -$90.3K -4,469 -26%
ProShare Advisors
121
ProShare Advisors
Maryland
$248K +$8.71K +431 +4%
Mitsubishi UFJ Asset Management
122
Mitsubishi UFJ Asset Management
Japan
$248K -$78.7K -3,896 -24%
Handelsbanken Fonder
123
Handelsbanken Fonder
Sweden
$244K +$249K +12,300 New
LPL Financial
124
LPL Financial
California
$237K -$26.3K -1,300 -10%
NC
125
NinePointTwo Capital
California
$237K – – –
3 4
5
6 7

RCKT Hedge Fund Activity: Q2 2023 in Review

164 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q2 2023, worth a combined $1.52B — up 13% from $1.34B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RCKT positions and 17 closed out — a net gain of 1 holder — while 61 added to existing stakes and 54 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $20.9M. The largest seller was RA Capital Management, exiting entirely with an estimated $19.4M sold.

  • 164 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q2 2023, up from 163 in Q1 2023.
  • Funds reported $1.52B of Rocket Pharmaceuticals stock for Q2 2023, up 13% quarter-over-quarter.
  • 18 funds opened new Rocket Pharmaceuticals positions in Q2 2023 and 17 closed out, a net change of +1 holder.
  • The largest Rocket Pharmaceuticals buyer in Q2 2023 was Wellington Management Group, an estimated $20.9M added.
  • The largest Rocket Pharmaceuticals seller in Q2 2023 was RA Capital Management, an estimated $19.4M sold.

Based on aggregated 13F filings for Q2 2023.